Inspire Medical Systems Inc. (INSP)
NYSE: INSPHealthcareMedical DevicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 67.45 -0.07%
INSP stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.95B
- P/E (TTM)
- 14.86
- Forward P/E
- 43.60
- EPS (TTM)
- $4.54
- Dividend yield
- None
- 52-week range
- 38.91 – 147.03
- Day range
- 66.50 – 68.37
- Volume / Avg
- 1.15M / 795.67K
- Beta
- —
- Shares outstanding
- 28.91M
- Next earnings
- Nov 2, 2026
52-week range
INSP stock today
Inspire Medical Systems (INSP) closed at $67.45 on Oct 7, down 1.10% (-$0.75), versus the S&P 500's 0.22% decline. At this level, INSP sits in the middle of its 52-week range of $38.91 to $147.03: 54.1% below the high, set on Dec 10, 2025 and 73.3% above the low. INSP is down 26.8% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 12.1%.
Inspire Medical Systems trades at 14.9x its trailing twelve-month earnings per share of $4.54. Its forward P/E of 43.6x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year. Inspire Medical Systems's next earnings report is expected on Nov 2, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Inspire Medical Systems
Company profileInspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. Timothy P. Herbert
- Headquarters
- Golden Valley, MN
- Employees
- 1,333
- IPO year
- 2018
- Website
- inspiresleep.com
Analyst forecast
ForecastConsensus (18 analysts)
hold
Avg. price target
$65.00-3.63%
- Strong buy 0
- Buy 4
- Hold 11
- Sell 1
- Strong sell 2
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 2, 2026
- EPS estimate
- $0.10
INSP news
All INSP newsInspire Medical Systems peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ALMRAlamar Biosciences Inc. | 27.77 | -13.92% | $1.93B | vs INSP |
| ESTAEstablishment Labs Holdings Inc. | 63.85 | -2.21% | $1.90B | vs INSP |
| AXGNAxogen Inc. | 36.04 | -0.74% | $2.11B | vs INSP |
| BFLYButterfly Network Inc. Class A | 8.27 | -4.94% | $2.20B | vs INSP |
| NVCRNovoCure Limited | 14.66 | -2.07% | $1.71B | vs INSP |
| UFPTUFP Technologies Inc. | 292.87 | -3.30% | $2.27B | vs INSP |
| ATECAlphatec Holdings Inc. | 10.25 | -2.75% | $1.58B | vs INSP |
| NEOGNeogen Corporation | 11.68 | -2.34% | $2.55B | vs INSP |
Indexes, lists and sector
Appears in lists
Inspire Medical Systems stock FAQ
What is Inspire Medical Systems's stock price today?
INSP last traded at $67.45 as of Oct 7, 4:00 PM EDT, down 1.10% on the day. Prices are delayed at least 15 minutes.
When is Inspire Medical Systems's next earnings date?
Inspire Medical Systems is expected to report earnings on Monday, November 2, 2026. Analysts expect EPS of $0.10.
What is INSP's P/E ratio?
INSP trades at a trailing P/E ratio of 14.86 and a forward P/E of 43.60.
Who is Inspire Medical Systems's CEO?
Mr. Timothy P. Herbert is the chief executive officer of Inspire Medical Systems Inc., which has about 1,333 employees.
What is the INSP 52-week high?
The 52-week high for INSP is $147.03 and the 52-week low is $38.91. The stock is currently 54.1% below its high.